Jane Street’s CONMED CNMD Stock Holding History

Jane Street’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$492K	Buy	+13,900	New	+$566K	﹤0.01%	8077
2023 Q4	–	Sell	-20,000	Closed	-$2.02M	–	9240
2023 Q3	$2.02M	Sell	20,000 -84,200	-81%	-$9.67M	﹤0.01%	4044
2023 Q2	$14.2M	Buy	104,200 +78,600	+307%	+$9.6M	﹤0.01%	1545
2023 Q1	$2.66M	Sell	25,600 -14,800	-37%	-$1.43M	﹤0.01%	3354
2022 Q4	$3.58M	Buy	40,400 +26,800	+197%	+$2.22M	﹤0.01%	2956
2022 Q3	$1.09M	Buy	13,600 +3,500	+35%	+$330K	﹤0.01%	5260
2022 Q2	$967K	Sell	10,100 -2,400	-19%	-$288K	﹤0.01%	5538
2022 Q1	$1.86M	Buy	12,500 +5,600	+81%	+$782K	﹤0.01%	4893
2021 Q4	$978K	Buy	6,900 +700	+11%	+$99.1K	﹤0.01%	5947
2021 Q3	$811K	Buy	6,200 +1,700	+38%	+$222K	﹤0.01%	6331
2021 Q2	$618K	Buy	+4,500	New	+$616K	﹤0.01%	6842

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Jane Street's CNMD Position: Q1 2026 in Review

Jane Street reduced its CONMED (CNMD) stake by 65% in Q1 2026, selling an estimated $7.32M and leaving 96,923 shares worth $3.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4114.

Jane Street first reported a position in CNMD in Q1 2020 and has held it in 24 quarters since. The position peaked at $11.2M in Q4 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

Jane Street held 96,923 shares of CONMED worth $3.43M as of Q1 2026.
Jane Street sold 179,935 CONMED shares in Q1 2026, an estimated $7.32M.
CONMED made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4114 holding.
Jane Street first reported a position in CONMED in Q1 2020 and has held it in 24 quarters since.
Jane Street's CONMED position peaked at $11.2M in Q4 2025.
236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.